- Fund Type: FCP
- Objective: Region Fund-OECD Countries
- Asset Class: Equity
- Geographic Focus: OECD Countries
N-FONDS NR.3 STRATEGIE HNLUX
+ Add to WatchlistHANNR3S:LX
109.21 EUR 0.09 0.08%As of 01:59:30 ET on 05/17/2013.
Snapshot for N-FONDS NR.3 STRATEGIE HNLUX (HANNR3S)
| Year To Date: | +4.59% | 3-Month: | +4.35% | 3-Year: | +2.89% | 52-Week Range: | 93.14 - 109.30 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +4.00% | 1-Year: | +12.87% | 5-Year: | -0.05% | Beta vs LUXXX: | 0.78 |
Fund Profile & Information for HANNR3S
N-FONDS NR.3 STRATEGIE HNLUX is an open-end investment fund incorporated in Luxembourg. The Fund's objective is capital appreciation. The Fund invests primarily in equities issued in OECD member countries.
| Inception Date: | 10-15-2001 | Telephone: | +352.2735.71.10 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | - | ||
Fundamentals for HANNR3S
| NAV | (on 2013-05-17) 109.21 |
|---|---|
| Assets (M) | (on 2013-05-14) 19.42 |
| Fund Leveraged | N |
| Minimum Investment | 0.00 |
| Minimum Subsequent Investment | - |
Dividends for HANNR3S
No dividends reported
Fees & Expenses for HANNR3S
| Front Load | 3.00 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 1.65 |
| Redemption Fee | 0.00 |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for HANNR3S
Filing Date: 02/28/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Bayer AG | 15,000 | 1,107,900 | 6.581% |
| Unilever NV | 27,000 | 798,255 | 4.742% |
| Henkel AG & Co KGaA | 11,500 | 770,845 | 4.579% |
| L'Oreal SA | 6,600 | 748,770 | 4.448% |
| C 0 09/19/13 | 23,000 | 711,850 | 4.229% |
| Stada Arzneimittel AG | 24,500 | 709,888 | 4.217% |
| BASF SE | 9,500 | 684,855 | 4.068% |
| SAP AG | 11,300 | 672,237 | 3.993% |
| Sanofi | 9,400 | 671,348 | 3.988% |
| Volkswagen AG | 4,000 | 667,800 | 3.967% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page